Regulatory News In Brief
This article was originally published in The Gray Sheet
Executive Summary
Post-inspection response program: Beginning Sept. 15, FDA will consider industry responses to Form 483 inspection reports received within 15 days of the report's release when deciding whether to send a warning letter, FDA explains in an Aug. 11 Federal Register 1notice. Timely responses do not preclude FDA from issuing a warning letter. FDA Commissioner Margaret Hamburg announced the 15-day post-inspection deadline for company responses to FDA's inspection findings at a Food and Drug Law Institute meeting Aug. 6 (2"The Gray Sheet" Aug. 10, 2009). FDA plans to test out the response review program for 18 months and then decide whether to implement it permanently
You may also be interested in...
Abbott's New Glucose Test Strips Are First To Address Fatal Product Flaw
With a little extra push from FDA, Abbott gained 510(k) clearance May 14 for its new FreeStyle Lite blood glucose test strips, designed to remedy a potentially life threatening flaw in the product
Abbott's New Glucose Test Strips Are First To Address Fatal Product Flaw
With a little extra push from FDA, Abbott gained 510(k) clearance May 14 for its new FreeStyle Lite blood glucose test strips, designed to remedy a potentially life threatening flaw in the product
Facility Registration, Import Problems Keep CDRH Compliance Office Busy
CDRH Compliance Director Tim Ulatowski gave an update last week on activities at his office, including import safety efforts and a notable warning letter push